Medicinal product name | Yaldigo 1 g suppositories |
---|---|
Pharmaceutical form | Suppository |
Strength | 1 g |
Information from the MAH on shortages | No information on expected shortages |
Legal status | Prescription (Pr.) |
Package leaflet | 07-11-2023 |
Summary of product characteristics | 07-11-2023 |
ATC code | A07EC02 – Antidiarrheals, intestinal antiinflammatory/antiinfective agents |
Information for Marketing authorisation holders | View |
Medicinal products (5)
Availability of medicinal product | Wholesalers | Package size, content | Primary packaging | Maximum admissible pharmacy price (€ incl. VAT) | Product No. | Labelling |
---|---|---|---|---|---|---|
Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N10 (1 g) |
PVC/PE | 21-0007-01 |
Labelling text May 20, 2021 |
|
Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N20 (1 g) |
PVC/PE | 21-0007-02 |
Labelling text May 20, 2021 |
|
Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N30 (1 g) |
PVC/PE | € 70.30 | 21-0007-03 |
Labelling text May 20, 2021 |
Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N60 (1 g) |
PVC/PE | 21-0007-04 |
Labelling text May 20, 2021 |
|
Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N90 (1 g) |
PVC/PE | 21-0007-05 |
Labelling text May 20, 2021 |
Registration information
Marketing authorisation No. | 21-0007 |
---|---|
Date of authorisation | Jan 19, 2021 |
Marketing authorisation holder, country | Tillotts Pharma AB, Sweden |